A biotech company tries to retrofit a lung drug for Covid-19 after effects

A biotech company tries to retrofit a lung drug for Covid-19 after effects

STAT Plus: A biotech company tries to retrofit a lung drug to prevent Covid-19’s after effects

By DAMIAN GARDE

FEATURECHINA VIA AP

PureTech Health, a biotech company in Boston, believes it might have a treatment for Covid-19 survivors facing the risk of long-term lung injuries.

READ MORE